[Use of the metabolic products of lactic acid bacteria strain 317/402 in suppurative surgery].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to K M Dekhtsunian.
Explore the source record for details and available documents.
The prophylaxis of purulent omphalitis is an urgent problem of epidemiology and obstetrics. A high morbidity rate in omphalitis and umbilical sepsis has been noted after the treatment of the umbilical bed by commonly used methods. As revealed in our investigations, two new treatment methods have proved to be highly effective for this purpose: treatment with the preparation Narine-phi containing the metabolic products of lactobacterial strain 317/402 Narine and treatment with the film-forming preparation Lifuzol. Both methods have made it possible to achieve a significant decrease in the contamination of the umbilical bed of newborns by hospital microorganisms and in morbidity rate in purulent omphalitis as compared with those in the control group.
Explore the source record for details and available documents.
Investigations carried out by the authors have disclosed that practically all infants discharged from maternity clinics are S. aureus carriers, and 91.66-97.06% of them have proved to be epidemiologically dangerous as the source of infection. The use of lactic-acid bacteria, strain 317/407 "Narine" for the colonization of the nasal cavity of infants has led to a decrease in the total number of carriers up to 55.17%, and in the number of epidemiologically significant carriers up to 12.5%.
The study of antagonism between S. aureus hospital strains and lactic acid bacteria, strain 317/402 "Nariné", revealed that the latter possessed high antagonistic activity. A new method for the sanitation of carriers of S. aureus hospital strains was developed; this method made it possible to limit the epidemiological significance of 82% of these strains.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.